secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pulmonx Corp (LUNG)
CIK:        0001127537
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001127537-24-000012
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulmonx CEO Glen French retires; Steve Williamson appointed President and CEO effective March 15, 2024
--------------------------------------------------------------------------------

- Glen French resigns as CEO effective March 15; will serve as Senior Advisor until May 1, then remain on Board.
- Steve Williamson named CEO and Board member; previously Chief Commercial Officer at Outset Medical.
- Williamson receives $580k base salary, 75% target bonus, and equity grants totaling $5M (option + RSU).
- Board reduces size to eight directors after Alissa Hsu Lynch declines re-election at 2024 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1127537/000112753724000012/0001127537-24-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1127537/000112753724000012/lung-20240221.htm
  HTML page:      https://secwatch.observer/filing/0001127537-24-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer